Optimization and Validation of Electric Acoustic Stimulation (EAS) Mapping as a Function of Residual Hearing After CI-Implantation
1 other identifier
interventional
12
0 countries
N/A
Brief Summary
The aim of this clinical study is to investigate how the fitting of an EAS (electrical acoustic stimulation) based on electrocochleography (ECochG) thresholds compares to fitting based on pure tone audiogram thresholds in terms of speech intelligibility in quiet and noise. The personal feedback from the study participants regarding the question of better fitting and the resulting sound quality should also be included in the analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 12, 2026
CompletedFirst Posted
Study publicly available on registry
March 17, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
April 24, 2026
April 1, 2026
1.5 years
March 12, 2026
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Speech Recognition Threshold (SRT50)
The primary outcome measure is the Speech Recognition Threshold (SRT50) at three months after EAS fitting (either objective or subjective EAS fitting in a cross-over design). The SRT50 measures speech understanding in noise and is defined as the Signal-to-Noise Ratio (measured in dB SNR) which yields 50% speech understanding, as determined by the OLSA test.
Three months after EAS fitting
Secondary Outcomes (3)
Subjective level of auditory benefit
Three months after EAS fitting
Subjectively preferred EAS fitting method
at the end of the study, six months after baseline
Post-operative ECochG and PTA tresholds
Three months after EAS fitting (either objective or subjective EAS fitting)
Study Arms (2)
Sequence A, subjective followed by objective fitting
OTHERIn this sequence, the EAS is fitted in the first three months (period 1) using the subjective fitting method based on the thresholds in the pure tone audiogram. This is followed by three months (period 2) fitting using the objective fitting method based on the thresholds from electrocochleography.
Sequence B, objective followed by subjective fitting
OTHERIn this sequence, the EAS is fitted in the first three months (period 1) using the objective fitting method based on the thresholds from electrocochleography. This is followed by three months (period 2) fitting using the subjective fitting method based on the thresholds in the pure tone audiogram.
Interventions
Measured ECochG thresholds will be used in the initial EAS fitting in period 1 for sequence B. For sequence A, the ECochG-based EAS fitting (with up-to-date ECochG thresholds) will take place three months later at the beginning of period 2.
The control intervention is the subjective EAS fitting based on PTAs. This is provided to sequence A at the beginning of period 1 baseline and to sequence B at the beginning of period 2.
Eligibility Criteria
You may qualify if:
- Patients aged between 18-85 years.
- Cochlear Implant (CI) candidates with measurable post-operative low-frequency residual hearing (125Hz \<65dB, 250Hz \<65dB, 500Hz \<65dB).
- Only patients with MED-EL EAS.
- Written informed consent must be obtained prior to study start.
You may not qualify if:
- Patients with cognitive impairments who, as a result, lack the capacity to make decisions.
- Uncooperative patients regarding pure tone audiometry thresholds measurements.
- Morbus Menière or intracochlear/ vestibular schwannoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Luzerner Kantonsspitallead
- MED-EL Elektromedizinische Geräte GesmbHcollaborator
Related Publications (9)
Schaefer S, Sahwan M, Metryka A, Kluk K, Bruce IA. The benefits of preserving residual hearing following cochlear implantation: a systematic review. Int J Audiol. 2021 Aug;60(8):561-577. doi: 10.1080/14992027.2020.1863484. Epub 2021 Jan 10.
PMID: 33426931BACKGROUNDRajan G, Tavora-Vieira D, Baumgartner WD, Godey B, Muller J, O'Driscoll M, Skarzynski H, Skarzynski P, Usami SI, Adunka O, Agrawal S, Bruce I, De Bodt M, Caversaccio M, Pilsbury H, Gavilan J, Hagen R, Hagr A, Kameswaran M, Karltorp E, Kompis M, Kuzovkov V, Lassaletta L, Yongxin L, Lorens A, Manoj M, Martin J, Mertens G, Mlynski R, Parnes L, Pulibalathingal S, Radeloff A, Raine CH, Rajeswaran R, Schmutzhard J, Sprinzl G, Staecker H, Stephan K, Sugarova S, Zernotti M, Zorowka P, Van de Heyning P. Hearing preservation cochlear implantation in children: The HEARRING Group consensus and practice guide. Cochlear Implants Int. 2018 Jan;19(1):1-13. doi: 10.1080/14670100.2017.1379933. Epub 2017 Oct 26.
PMID: 29073844BACKGROUND15. Wagener KC, Kühnel V, Kollmeier B (1999b) Entwicklung und Evaluation eines Satztests für die deutsche Sprache III: Evaluation des Oldenburger Sprachtests. Z Audiol 38:86-95.
BACKGROUNDWagener KC, Kühnel V, Kollmeier B (1999a) Entwicklung und Evaluation eines Satztests für die deutsche Sprache I: Design des Oldenburger Satztests. Z Audiol 38:4-15.
BACKGROUNDHey M, Bohnke B, Mewes A, Munder P, Mauger SJ, Hocke T. Speech comprehension across multiple CI processor generations: Scene dependent signal processing. Laryngoscope Investig Otolaryngol. 2021 Jun 15;6(4):807-815. doi: 10.1002/lio2.564. eCollection 2021 Aug.
PMID: 34401506BACKGROUNDGifford RH, Sunderhaus LW, Dawant BM, Labadie RF, Noble JH. Cochlear implant spectral bandwidth for optimizing electric and acoustic stimulation (EAS). Hear Res. 2022 Dec;426:108584. doi: 10.1016/j.heares.2022.108584. Epub 2022 Jul 28.
PMID: 35985964BACKGROUNDGawliczek T, Mantokoudis G, Anschuetz L, Caversaccio MD, Weder S. Comparison of auditory brainstem response and electrocochleography to assess the coupling efficiency of active middle ear implants. Front Neurol. 2023 Sep 6;14:1231403. doi: 10.3389/fneur.2023.1231403. eCollection 2023.
PMID: 37745650BACKGROUNDDillon MT, O'Connell BP, Canfarotta MW, Buss E, Hopfinger J. Effect of Place-Based Versus Default Mapping Procedures on Masked Speech Recognition: Simulations of Cochlear Implant Alone and Electric-Acoustic Stimulation. Am J Audiol. 2022 Jun 2;31(2):322-337. doi: 10.1044/2022_AJA-21-00123. Epub 2022 Apr 8.
PMID: 35394798BACKGROUNDDalbert A, Weder S. [Application of extra- and intracochlear electrocochleography during and after cochlear implantation]. HNO. 2025 Jan;73(1):14-21. doi: 10.1007/s00106-024-01481-4. Epub 2024 May 18. German.
PMID: 38761228BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Armina Kreuzer, Dr.
Luzerner Kantonsspital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Audiologist
Study Record Dates
First Submitted
March 12, 2026
First Posted
March 17, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
April 24, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share